What are the target cells and receptors that are recognized by antiphospholipid antibodies?

Philip G. De Groot, ElenA Raschi, Keith R. McCrae, Silvia S. Pierangeli, Panayiotis G. Vlachoyiannopoulos, Rolf T. Urbanus

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The antiphospholipid syndrome (APS) is a noninflammatory autoimmune disease defined by the presence of antiphospholipid autoantibodies (aPL) in plasma of patients with venous and/or arterial thrombosis and/or recurrent complications of pregnancy. Animal studies in which antibodies isolated from patients with APS were injected into mice and hamsters suggest that there is a direct link between aPL and an increased risk of thrombosis and fetal loss. However, how these antibodies induce the increased risk is unknown and a subject of many speculations The most popular theory to explain the prothrombotic action of aPL is their ability to activate different cell types involved in the maintenance of the hemostatic balance. Many different receptors have been identified that are involved in the binding and activation of cells by the autoantibodies. In this overview, our present knowledge and the most important controversies on antiphospholipid antibody mediated cell activation are discussed.

Original languageEnglish
Title of host publicationAntiphospholipid Syndrome: Insights and Highlights from the 13Th International Congress on Antiphospholipid Antibodies
PublisherSpringer US
Pages103-113
Number of pages11
ISBN (Print)9781461431947, 9781461431930
DOIs
Publication statusPublished - Jan 1 2012

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'What are the target cells and receptors that are recognized by antiphospholipid antibodies?'. Together they form a unique fingerprint.

Cite this